U.S. markets closed

InVivo Therapeutics Holdings Corp. (NVIV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1500-0.0500 (-4.17%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
0
0
0
-
Operating Expense
9,645
11,497
12,767
24,593
Operating Income
-9,645
-11,497
-12,767
-24,593
Net Non Operating Interest Income Expense
52
254
206
115
Other Income Expense
-661
-587
-10,862
-2,267
Pretax Income
-10,254
-11,830
-23,423
-26,745
Net Income Common Stockholders
-10,254
-11,830
-23,423
-26,745
Diluted NI Available to Com Stockholders
-10,254
-11,830
-23,423
-26,745
Basic EPS
-
-0.0353
-0.1407
-0.6075
Diluted EPS
-
-0.0353
-0.1407
-0.6075
Basic Average Shares
-
335.349
166.334
43.932
Diluted Average Shares
-
335.349
166.334
43.932
Total Operating Income as Reported
-9,645
-11,497
-12,767
-24,593
Total Expenses
9,645
11,497
12,767
24,593
Net Income from Continuing & Discontinued Operation
-10,254
-11,830
-23,423
-26,745
Normalized Income
-10,254
-11,164
-11,258
-24,478
Interest Income
-
-
-
189
Interest Expense
-
-
-
74
Net Interest Income
52
254
206
115
EBIT
-9,645
-11,497
-12,767
-26,671
EBITDA
-9,321
-
-
-
Reconciled Depreciation
324
322
91
395
Net Income from Continuing Operation Net Minority Interest
-10,254
-11,830
-23,423
-26,745
Total Unusual Items Excluding Goodwill
-
-666
-12,165
-2,267
Total Unusual Items
-
-666
-12,165
-2,267
Normalized EBITDA
-9,321
-10,509
-511
-24,009
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0